Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro

Acta Pharmacologica Sinica

Volumn 29, Issue 7, 2008, Pages 847-852

  Zhang, Li ^a   Liu, Hou Jia ^b   Li, Tie Jun ^a   Yang, Yang ^a   Guo, Xian Ling ^a   Wu, Meng Chao ^b   Rui, Yao Cheng ^a   Wei, Li Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; CXCL16; Lentiviral vector; Oxidativelymodified, low density lipoprotein; Small interfering RNA; SR PSOX

Indexed keywords

CXCL16 CHEMOKINE; ENHANCED GREEN FLUORESCENT PROTEIN; LENTI NC PROTEIN; LENTI SR PSOXSI PROTEIN; LENTIVIRUS VECTOR; MACROPHAGE DERIVED CHEMOKINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLSERINE; SCAVENGER RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; CXCL16 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EXPRESSION VECTOR; FLOW CYTOMETRY; FOAM CELL; GENE; GENE CONSTRUCT; HUMAN; HUMAN CELL; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SR PSOX GENE; STAINING; VIRAL GENE DELIVERY SYSTEM; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; METABOLISM; MONOCYTE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE; CELL SURVIVAL; CHEMOKINES, CXC; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOAM CELLS; GENETIC VECTORS; HUMANS; LENTIVIRUS; MONOCYTES; RECEPTORS, SCAVENGER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

EID: 65849264973     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00823.x     Document Type: Article

References (25)

1. Gleissner CA, Leitinger N, Ley K. Effects of native and modified low-de nsi ty l i po pr ot e in s o n mo noc yt e r ec ru i tmen t in atherosclerosis. Hypertension 2007; 50: 276-83.
2. Evans CE, Mylchreest S, Charlton-Menys V, Durrington P. The role of hydrostatic pressure in foam cell formation upon exposure of macrophages to LDL and oxidized LDL. Atherosclerosis 2008; 197: 596-601.
3. Sun B, Boyanovsky BB, Connel ly MA, Shr idas P, van der Westhuyzen DR, Webb NR. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J Lipid Res 2007; 48: 2560-70.
4. Eguchi A, Murakami A, Ohigashi H. Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells. FEBS Lett 2006; 580: 3321-8.
5. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007; 100: 1634-42.
6. Quan Z, Yang H, Yang Y, Yan B, Cao R, Wen G, et al. Construction and functional analysis of a lent iviral expression vector containing a scavenger receptor (SR-PSOX) that binds uniquely phosphatidylser ine and oxidized l ipoprotein. Acta Biochim Biophys Sin (Shanghai) 2007; 39: 208-16.
7. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298-304.
8. Hundhausen C, Schulte A, Schulz B, Andrzejewski MG, Schwarz N, von Hundelshausen P, et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007; 178: 8064-72.
9. Hofnagel O, Luechtenborg B, Plenz G, Robenek H. Expression of the novel scavenger receptor SR-PSOX in cultured aort ic smooth muscle cells and umbilical endothelial cells. Arterioscler Thromb Vasc Biol 2002; 22: 710-1.
10. Jiang X, Shimaoka T, Kojo S, Harada M, Watarai H, Wakao H, et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005; 175: 2051-5.
11. Chandrasekar B, Bysani S, Mummidi S. CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 2004; 279: 3188-96.
12. Minami M, Kume N, Shimaoka T, Kataoka H, Hayashida K, Akiyama Y, et al. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2001; 21: 1796-800.
13. Wuttge DM, Zhou X, Sheikine Y, Wagsater D, Stemme V, Hedin U, et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004; 24: 750-5.
14. Sheikine Y, Sirsjo A. CXCL16/SR-PSOX-A friend or a foe in atherosclerosis? Atherosclerosis 2008; 197: 487-95.
15. Yang PY, Rui YC, Jin YX, Li TJ, Qiu Y, Zhang L, et al. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor expression in U937 foam cells. Acta Pharmacol Sin 2003; 24: 610-4.
16. Fish RJ, Kruithof EK. Short-term cytotoxic effects and longterm instability of RNAi delivered using lentiviral vectors. BMC Mol Biol 2004; 5: 9.
17. Jiang G, Li T, Qiu Y, Rui Y, Chen W, Lou Y. RNA interference for HIF-1alpha inhibits foam cells format ion in vitro. Eur J Pharmacol 2007; 562: 183-90.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 2001; 25: 402-8.
19. Tang Y, Ge YZ, Yin JQ. Exploring in vitro roles of siRNA in cardiovascular disease. Acta Pharmacol Sin 2007; 28: 1-9.
20. Wang H, Tan SS, Wang XY, Liu DH, Yu CS, Bai ZL, et al. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells. Acta Pharmacol Sin 2007; 28: 1968-74.
21. Gao LF, Wen LJ, Yu H, Zhang L, Meng Y, Shao YT, et al . Knockdown of Stat3 expression using RNAi inhibits growth of laryngeal tumors in vivo. Acta Pharmacol Sin 2006; 27: 347-52.
22. Thomas M, Greil J, Heidenreich O. Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials. Acta Pharmacol Sin 2006; 27: 273-81.
23. Yin R, Dong YG, Li HL. PPARgamma phosphorylation mediated by JNK MAPK: a potent ial role in macrophage-derived foam cell formation. Acta Pharmacol Sin 2006; 27: 1146-52.
24. Aslanian AM, Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 2006; 114: 583-90.
25. Lougheed M, Lum CM, Ling W, Suzuki H, Kodama T, Steinbrecher U. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem 1997; 272: 12938-44.